MINNEAPOLIS
--(BUSINESS WIRE)--Nov. 7, 2013--
Piper
Jaffray
(NYSE: PJC) is pleased to announce the hiring of
Josh
Schimmer
, MD as a managing director and senior research analyst based in
the firm’s
New York
office. Schimmer will be focused on small- and
mid-cap biotechnology companies with specific emphasis in core
therapeutic areas, commercialization and strategic partnerships.
Schimmer brings more than 10 years of experience to
Piper Jaffray
. He
joined the firm from
Lazard Capital Markets
, and was previously at
Cowen
& Co.
,
Leerink Swann
, Deutsche Banc and
Davidson Kempner
. Schimmer holds
a doctorate of medicine from the
University of Toronto
and a Master of
Business Administration degree from
Harvard Business School
.
"
Piper Jaffray
has a strong team of healthcare professionals and we are
excited to be adding another research specialist in biotechnology with
Josh's hire," commented
Steph
Wissink
, co-director of equity research for
Piper Jaffray
. "With
increased emphasis on core growth areas of biotech, we see opportunities
to serve the needs of our clients and build upon our market-leading
healthcare platform."
Piper Jaffray has a total of
30
senior research analysts
located in Minneapolis, New York, San
Francisco and Chicago. The firm provides coverage on approximately
575
companies
in the following key sectors: business & financial
services; clean technology & industrial growth; consumer; healthcare;
and technology, media & telecommunications.
About
Piper Jaffray
Piper Jaffray
is a leading investment
bank and asset management firm serving clients in the U.S. and
internationally. Proven advisory teams combine deep industry, product
and sector expertise with ready access to capital. Founded in 1895, the
firm is headquartered in
Minneapolis
and has offices across
the United
States
and in
London
and
Zurich
.
www.piperjaffray.com
Since 1895. Member
NYSE
and
SIPC
.
© 2013
Piper Jaffray & Co.
Source:
Piper Jaffray Companies
Piper Jaffray Companies
Pamela Steensland, +1 612-303-8184
